American Vanguard (AVD)
Market Price (8/31/2026): $2.19 | Market Cap: $62.7 MilSector: Materials | Industry: Fertilizers & Agricultural Chemicals
American Vanguard (AVD)
Market Price (8/31/2026): $2.19Market Cap: $62.7 MilSector: MaterialsIndustry: Fertilizers & Agricultural Chemicals
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Megatrend and thematic driversMegatrends include Food Security & Sustainable Agriculture, Advanced Materials, and Sustainable Resource Management. Themes include Crop Protection & Enhancement, Show more. | Weak multi-year price returns2Y Excs Rtn is -100%, 3Y Excs Rtn is -159% | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 383% Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -3.5%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.5%, Rev Chg QQuarterly Revenue Change % is -9.7% Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -8.2%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -9.3% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -91% Key risksAVD key risks include [1] significant financial instability and operational control deficiencies, Show more. |
| Megatrend and thematic driversMegatrends include Food Security & Sustainable Agriculture, Advanced Materials, and Sustainable Resource Management. Themes include Crop Protection & Enhancement, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -100%, 3Y Excs Rtn is -159% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 383% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -3.5%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.5%, Rev Chg QQuarterly Revenue Change % is -9.7% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -8.2%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -9.3% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -91% |
| Key risksAVD key risks include [1] significant financial instability and operational control deficiencies, Show more. |
Qualitative Assessment
AI Analysis | Feedback
American Vanguard (AVD) stock has lost about 25% since 4/30/2026 because of the following key factors:
1. American Vanguard reported significantly weaker financial results for fiscal Q2 2026 (ended June 30, 2026).
Net sales for fiscal Q2 2026 were $117 million, a 9% decline from $129 million in Q2 2025. The company's adjusted EBITDA decreased to $6.6 million in Q2 2026 from $11 million in the prior year period. Furthermore, American Vanguard posted an operating loss of $0.3 million and a widened net loss of $9.9 million in Q2 2026, compared to an operating income of $4.4 million and a net loss of $0.849 million in Q2 2025. Earnings per share (EPS) also deteriorated to ($0.34) in Q2 2026, from ($0.03) a year earlier.
2. Increased net debt and liquidity concerns raised questions about the company's financial health.
American Vanguard's net debt increased to $224.7 million as of June 30, 2026, up from $194.7 million at the end of fiscal Q1 2026. This was driven by peak working capital needs. The company's cash position also declined from $70.9 million in fiscal Q1 2026 to $43.9 million in fiscal Q2 2026. Quarterly interest expense nearly doubled, rising to $9.1 million from $4.5 million. As of July 31, 2026, the company's GF-Score stood at 56/100, reflecting weak growth metrics and a negative return on equity of -21.47%, along with an Altman Z score of 1.52, signaling financial distress risk.
Show more
American Vanguard (AVD) stock has lost about 25% since 4/30/2026 because of the following key factors:
1. American Vanguard reported significantly weaker financial results for fiscal Q2 2026 (ended June 30, 2026).
Net sales for fiscal Q2 2026 were $117 million, a 9% decline from $129 million in Q2 2025. The company's adjusted EBITDA decreased to $6.6 million in Q2 2026 from $11 million in the prior year period. Furthermore, American Vanguard posted an operating loss of $0.3 million and a widened net loss of $9.9 million in Q2 2026, compared to an operating income of $4.4 million and a net loss of $0.849 million in Q2 2025. Earnings per share (EPS) also deteriorated to ($0.34) in Q2 2026, from ($0.03) a year earlier.
2. Increased net debt and liquidity concerns raised questions about the company's financial health.
American Vanguard's net debt increased to $224.7 million as of June 30, 2026, up from $194.7 million at the end of fiscal Q1 2026. This was driven by peak working capital needs. The company's cash position also declined from $70.9 million in fiscal Q1 2026 to $43.9 million in fiscal Q2 2026. Quarterly interest expense nearly doubled, rising to $9.1 million from $4.5 million. As of July 31, 2026, the company's GF-Score stood at 56/100, reflecting weak growth metrics and a negative return on equity of -21.47%, along with an Altman Z score of 1.52, signaling financial distress risk.
3. A significant reduction in holdings by a major institutional investor signaled declining confidence.
On June 30, 2026, BlackRock, Inc. reduced its stake in American Vanguard by selling 1,182,351 shares at $2.80 per share, representing a 56.87% decrease in its position. This transaction accounted for 3.10% of BlackRock's total portfolio, indicating a notable reallocation away from the agriculture sector due to their focus on growth-oriented sectors. This substantial divestment by a major institutional investor suggests limited institutional confidence in American Vanguard's near-term recovery.
4. Challenging macroeconomic conditions in agricultural markets and rising freight costs impacted performance.
The company's CEO acknowledged "ongoing and dynamic crosscurrents affecting our agricultural markets and customers around the world." These challenging agricultural market conditions led to conservative buying practices among distributors and growers, resulting in deferred purchases and shifting order patterns. Specifically, international sales declined 18% in fiscal Q2 2026, partly due to El Nino dry conditions and softer demand in Brazil. Additionally, higher freight costs negatively impacted gross margins by an estimated 90 basis points in the first half of 2026, further pressuring profitability.
Show less
Stock Movement Drivers
Fundamental Drivers
The -24.0% change in AVD stock from 4/30/2026 to 8/30/2026 was primarily driven by a -23.0% change in the company's P/S Multiple.| (LTM values as of) | 4302026 | 8302026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.88 | 2.19 | -24.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 515 | 510 | -0.9% |
| P/S Multiple | 0.2 | 0.1 | -23.0% |
| Shares Outstanding (Mil) | 29 | 29 | -0.3% |
| Cumulative Contribution | -24.0% |
Market Drivers
4/30/2026 to 8/30/2026| Return | Correlation | |
|---|---|---|
| AVD | -24.0% | |
| Market (SPY) | 7.1% | 17.0% |
| Sector (XLB) | 3.3% | 35.1% |
Fundamental Drivers
The -56.9% change in AVD stock from 1/31/2026 to 8/30/2026 was primarily driven by a -55.0% change in the company's P/S Multiple.| (LTM values as of) | 1312026 | 8302026 | Change |
|---|---|---|---|
| Stock Price ($) | 5.08 | 2.19 | -56.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 530 | 510 | -3.7% |
| P/S Multiple | 0.3 | 0.1 | -55.0% |
| Shares Outstanding (Mil) | 29 | 29 | -0.5% |
| Cumulative Contribution | -56.9% |
Market Drivers
1/31/2026 to 8/30/2026| Return | Correlation | |
|---|---|---|
| AVD | -56.9% | |
| Market (SPY) | 11.5% | 19.8% |
| Sector (XLB) | 8.4% | 32.2% |
Fundamental Drivers
The -43.3% change in AVD stock from 7/31/2025 to 8/30/2026 was primarily driven by a -40.5% change in the company's P/S Multiple.| (LTM values as of) | 7312025 | 8302026 | Change |
|---|---|---|---|
| Stock Price ($) | 3.86 | 2.19 | -43.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 529 | 510 | -3.5% |
| P/S Multiple | 0.2 | 0.1 | -40.5% |
| Shares Outstanding (Mil) | 28 | 29 | -1.1% |
| Cumulative Contribution | -43.3% |
Market Drivers
7/31/2025 to 8/30/2026| Return | Correlation | |
|---|---|---|
| AVD | -43.3% | |
| Market (SPY) | 22.7% | 18.3% |
| Sector (XLB) | 23.0% | 34.9% |
Fundamental Drivers
The -87.7% change in AVD stock from 7/31/2023 to 8/30/2026 was primarily driven by a -85.8% change in the company's P/S Multiple.| (LTM values as of) | 7312023 | 8302026 | Change |
|---|---|---|---|
| Stock Price ($) | 17.86 | 2.19 | -87.7% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 585 | 510 | -12.8% |
| P/S Multiple | 0.9 | 0.1 | -85.8% |
| Shares Outstanding (Mil) | 28 | 29 | -1.0% |
| Cumulative Contribution | -87.7% |
Market Drivers
7/31/2023 to 8/30/2026| Return | Correlation | |
|---|---|---|
| AVD | -87.7% | |
| Market (SPY) | 74.0% | 20.4% |
| Sector (XLB) | 31.0% | 32.1% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| AVD Return | 6% | 33% | -49% | -58% | -17% | -43% | -86% |
| Peers Return | 48% | 15% | -21% | -7% | -3% | 17% | 43% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 13% | 106% |
Monthly Win Rates [3] | |||||||
| AVD Win Rate | 42% | 42% | 50% | 25% | 42% | 38% | |
| Peers Win Rate | 65% | 58% | 42% | 48% | 50% | 57% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| AVD Max Drawdown | -36% | -29% | -63% | -67% | -46% | -62% | |
| Peers Max Drawdown | -20% | -31% | -41% | -24% | -36% | -30% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: CTVA, FMC, NTR, MOS, CF.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 8/28/2026 (YTD)
How Low Can It Go
| Event | AVD | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -37.0% | -18.8% |
| % Gain to Breakeven | 58.8% | 23.1% |
| Time to Breakeven | 150 days | 79 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -12.6% | -24.5% |
| % Gain to Breakeven | 14.4% | 32.4% |
| Time to Breakeven | 12 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -34.4% | -33.7% |
| % Gain to Breakeven | 52.5% | 50.9% |
| Time to Breakeven | 297 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -26.0% | -19.2% |
| % Gain to Breakeven | 35.1% | 23.8% |
| Time to Breakeven | 78 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -11.0% | -12.2% |
| % Gain to Breakeven | 12.3% | 13.9% |
| Time to Breakeven | 17 days | 62 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -28.7% | -6.8% |
| % Gain to Breakeven | 40.2% | 7.3% |
| Time to Breakeven | 205 days | 15 days |
In The Past
American Vanguard's stock fell -37.0% during the 2025 US Tariff Shock. Such a loss loss requires a 58.8% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | AVD | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -37.0% | -18.8% |
| % Gain to Breakeven | 58.8% | 23.1% |
| Time to Breakeven | 150 days | 79 days |
| 2020 COVID-19 Crash | ||
| % Loss | -34.4% | -33.7% |
| % Gain to Breakeven | 52.5% | 50.9% |
| Time to Breakeven | 297 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -26.0% | -19.2% |
| % Gain to Breakeven | 35.1% | 23.8% |
| Time to Breakeven | 78 days | 105 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -28.7% | -6.8% |
| % Gain to Breakeven | 40.2% | 7.3% |
| Time to Breakeven | 205 days | 15 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -28.8% | -17.9% |
| % Gain to Breakeven | 40.4% | 21.8% |
| Time to Breakeven | 141 days | 123 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -59.0% | -53.4% |
| % Gain to Breakeven | 144.1% | 114.4% |
| Time to Breakeven | 1203 days | 1085 days |
| Summer 2007 Credit Crunch | ||
| % Loss | -29.0% | -8.6% |
| % Gain to Breakeven | 40.9% | 9.5% |
| Time to Breakeven | 34 days | 47 days |
In The Past
American Vanguard's stock fell -37.0% during the 2025 US Tariff Shock. Such a loss loss requires a 58.8% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About American Vanguard (AVD)
American Vanguard Corporation (AVD) is a specialty chemicals company that develops, manufactures, and markets a diverse range of chemical and biological products. The company's operations span the entire lifecycle from product formulation to distribution, serving multiple sectors both domestically and internationally.
AVD's primary product portfolio includes agricultural chemicals such as insecticides, fungicides, herbicides, molluscicides, and soil fumigants. They also offer products for soil health, plant nutrition, and growth regulation. These solutions are produced in various forms, including liquid, powder, and granular, to cater to different application needs. Beyond manufacturing, AVD also distributes other end-use chemical and biological products.
The company primarily serves agricultural markets, providing essential products for crop protection and enhancement. Additionally, it caters to commercial markets for turf and ornamental plant care, and has applications in human and animal health protection. American Vanguard distributes its products through a comprehensive network comprising national distribution companies, buying groups, and its own sales force and wholly owned distributors.
AI Analysis | Feedback
It's like a smaller, specialized BASF or DuPont, but entirely focused on chemicals for agriculture and plant health.
Think of it as the 'Johnson & Johnson' for the agricultural sector, providing a wide array of specialty chemicals for crop protection, soil health, and plant nutrition.
AI Analysis | Feedback
- Insecticides: Chemicals designed to control insect pests.
- Fungicides: Chemicals used to prevent and control fungal diseases in plants.
- Herbicides: Chemicals specifically formulated for weed control.
- Molluscicides: Products used to manage mollusc populations.
- Soil Health & Plant Nutrition Products: Solutions aimed at improving soil vitality and delivering essential nutrients to plants.
- Plant Growth Regulators: Chemicals that modify or regulate the growth processes of plants.
- Soil Fumigants: Specialized chemicals used to sterilize soil by eliminating pests and pathogens.
- End-Use Crop Protection Products: A range of chemical and biological products marketed for direct application in crop cultivation.
- Chemical Distribution Services: The distribution of specialty chemicals primarily for turf and ornamental markets.
AI Analysis | Feedback
American Vanguard (AVD) primarily sells its specialty chemical products to other companies rather than directly to individual consumers. The company operates on a business-to-business (B2B) model, distributing its products through a network of partners.
Based on company disclosures, its major customers are not publicly named but fall into the following general categories:
- National Distribution Companies: These are large-scale distributors specializing in agricultural, commercial, and turf & ornamental chemical products, which then supply a wide array of end-users including farmers, landscapers, and various commercial operations.
- Buying Groups or Co-operatives: These organizations represent numerous agricultural producers or businesses, allowing them to collectively purchase products from suppliers like American Vanguard at potentially more favorable terms.
- Wholly Owned Distributors: American Vanguard also uses its own distribution channels and subsidiaries to reach specific markets or customer segments.
While American Vanguard's financial filings (e.g., 10-K reports) indicate that a significant portion of its total net sales comes from a few major, unnamed customers, the specific names of these customer companies and their symbols are not publicly disclosed by the company due to confidentiality.
AI Analysis | Feedback
AI Analysis | Feedback
Douglas A. ("Dak") Kaye III Chief Executive Officer
Mr. Kaye was appointed CEO in December 2024. Prior to joining American Vanguard in 2024, he held various senior leadership roles at Albaugh LLC, a global crop protection company, including President, North America, and Group Chief Commercial Officer. He also served as President of Albaugh's European region for seven years. Before Albaugh, Mr. Kaye was the CFO and a Director at a non-crop subsidiary of the crop protection company Adama and previously held the role of Co-CEO at an international automotive logistics organization. He began his career at Arthur Andersen, LLP.
David T. Johnson Chief Financial Officer
Mr. Johnson has served as Vice President, CFO, and Treasurer of American Vanguard since March 2008. Prior to his tenure at American Vanguard, he was the Finance Director for Amcor Flexibles UK Ltd., a manufacturer of decorative packaging and a subsidiary of Amcor, from June 2003 through March 2008. Before that, he served as Vice President of Finance for Sterer Engineering, a subsidiary of Eaton Aerospace, from April 2001 through June 2003.
Timothy J. Donnelly Chief Information Officer, General Counsel & Secretary
Mr. Donnelly has served as Chief Information Officer, General Counsel, and Secretary of American Vanguard. He joined the company in October 2005 as Vice President, General Counsel and Assistant Secretary, was appointed Secretary in June 2007, and assumed responsibility for Human Resources and Risk Management in 2009. Prior to American Vanguard, from September 2000 through October 2005, Mr. Donnelly served as Vice President, General Counsel and Secretary for DDi Corp. (Nasdaq—DDIC), a manufacturer of printed circuit boards. He also held roles as Assistant General Counsel at Rockwell International Corporation and an Associate at the law firm Latham & Watkins.
Shirin Khosravi Chief Human Resources Officer
Ms. Khosravi joined American Vanguard as Senior Vice President of Human Resources in October 2023. She brings over 30 years of progressive international human resources experience from various Fortune 500 companies, including Dover Corporation, CRH, and Holcim.
Mike DiPaola Chief Commercial Officer
Mr. DiPaola was appointed Chief Commercial Officer in January 2026. He joined American Vanguard in February 2025 and previously served as Senior Vice President of Strategy, Marketing, & R&D, where he led strategic initiatives, product development, regulatory and government affairs, mergers and acquisitions, marketing strategies, and research and development. Prior to American Vanguard, Mr. DiPaola was Chief Commercial Officer and General Manager at Taranis, an AI-powered crop intelligence platform. Earlier in his career, he held senior leadership positions at Syngenta and Southern States Cooperative.
AI Analysis | Feedback
Key Risks to American Vanguard (AVD)
-
Regulatory Pressures and Product Portfolio Transformation
American Vanguard faces significant risks from evolving regulatory policies that are phasing out older chemical products. The U.S. Environmental Protection Agency (EPA) has, for example, suspended registrations for dimethyl tetrachloroterephthalate (DCPA), also known as Dacthal, a key product for American Vanguard, due to reported health risks. This regulatory action necessitated a substantial charge for the collection and disposal of the product. This environment mandates a costly and strategic pivot of the company's product portfolio towards high-growth biologicals and digital agriculture technologies to maintain competitiveness, requiring significant investment while managing the decline of legacy products. -
Intense Competition and Market Pricing Pressures
Operating within a fiercely competitive agrochemical sector dominated by much larger industry giants, American Vanguard faces a scale disadvantage and a significant research and development (R&D) investment gap. The global biologicals market is rapidly growing, creating both opportunities and disruptive forces as the industry shifts away from traditional synthetic pesticides. This shift, coupled with a brutal pricing environment and hyper-aggressive discounting by rivals, has led to substantial pressure on American Vanguard's gross margins and net sales. -
Supply Chain Vulnerabilities and Operational Execution Challenges
American Vanguard is exposed to supply chain fragilities due to its reliance on a limited number of suppliers for critical raw materials, with some components available from single or very few sources globally. Disruptions in the global supply chain, including those from sourcing and manufacturing outside the U.S., tariffs, and international trade disputes, continue to pose risks of delays and raw material unavailability. Furthermore, the company has faced internal operational execution challenges, including reported material weaknesses in its internal controls over financial reporting, leading to delayed SEC filings and complications related to an Enterprise Resource Planning (ERP) system rollout. A recent ransomware attack also highlights cybersecurity as an ongoing operational risk.
AI Analysis | Feedback
AI Analysis | Feedback
American Vanguard Corporation operates in several addressable markets for its main agricultural chemical products.
Herbicides
- The global herbicides market was valued at approximately USD 32.47 billion in 2025 and is projected to grow to USD 51.89 billion by 2034.
- The U.S. herbicides market is estimated at USD 11.45 billion in 2025 and is expected to reach USD 14.37 billion by 2030.
Fungicides
- The global fungicides market size was valued at USD 25.34 billion in 2025 and is projected to grow from USD 26.92 billion in 2026 to USD 43.73 billion by 2034.
- The United States fungicide market size reached around USD 1.38 billion in 2025 and is projected to grow to nearly USD 1.85 billion by 2035.
Insecticides
- The global insecticides market size was calculated at USD 21.38 billion in 2024 and is predicted to increase to approximately USD 36.43 billion by 2034.
- The U.S. insecticides market size is estimated at USD 7.98 billion in 2025 and is expected to reach USD 9.85 billion by 2030.
Soil Fumigants
- The global soil fumigant market size was valued at USD 2.32 billion in 2024 and is expected to reach USD 3.79 billion by 2033.
- The U.S. agricultural fumigants market was valued at USD 375.0 million in 2024.
AI Analysis | Feedback
American Vanguard Corporation (AVD) is expected to drive future revenue growth over the next two to three years through several key initiatives and market recoveries:
-
Recovery from Industry Destocking and Improved Agricultural Input Demand: The company anticipates a rebound from the global destocking within the distribution channel that has impacted sales, coupled with an expected improvement in overall agricultural input demand. This normalization of procurement patterns is projected to accelerate revenue growth in the coming years.
-
Business and Digital Transformation Initiatives: American Vanguard is implementing comprehensive business and digital transformation efforts. These initiatives aim to optimize manufacturing, reduce raw material and selling expenses, enhance operating leverage, and create a more efficient platform for sustained growth and profitability.
-
Expansion of Green Solutions Portfolio: AVD is strategically positioned for a sustainability-minded future through its "Green Solutions" portfolio. This segment includes over 120 biological solutions, such as specialty nutritionals, biopesticides, biostimulants, and biofertilizers, which are expected to contribute to revenue growth as demand for sustainable agricultural inputs increases.
-
Advancement in Precision Agriculture Technologies: The company is a recognized leader in precision agriculture, particularly with its SIMPAS prescriptive application and Ultimus measure/record/verify technologies. These technologies enable targeted application of crop protection and bio-nutritional inputs, representing a key area for technological innovation and market expansion.
AI Analysis | Feedback
Share Repurchases
- In May 2023, American Vanguard's Board of Directors authorized a program to repurchase up to $15 million of common stock over the subsequent twelve months, commencing in June 2023.
- The company executed an accelerated share repurchase (ASR) plan of $20 million in August 2022, supplementing an existing 10b5-1 repurchase plan from March 2022.
- In August 2021, the Board approved a program for repurchasing up to 300,000 shares of common stock over six months to help offset the expansion of outstanding shares from employee equity awards.
- No common stock repurchases were made in 2024.
Share Issuance
- The number of common shares issued increased from 34,794,548 at December 31, 2024, to 34,850,030 at March 31, 2025, and further to 34,970,687 at September 30, 2025.
Outbound Investments
- In October 2023, American Vanguard acquired Punto Verde, an Ecuadorian company specializing in the distribution of crop protection products.
- AVD Australia acquired 100% of AgNova, an Australian company focused on specialty crop protection and production solutions, in October 2020.
- AMVAC, a subsidiary of American Vanguard, completed the purchase of all outstanding shares of Agrinos and certain intellectual property rights in October 2020.
Capital Expenditures
- American Vanguard reported capital expenditures of -$7.28 million in fiscal year 2024, -$11.88 million in fiscal year 2023, -$13.26 million in fiscal year 2022, and -$9.52 million in fiscal year 2021.
- The company anticipates capital expenditures of approximately $10 million for 2025, with an allocation focus on debt reduction.
- Capital expenditure efforts are directed towards investments in manufacturing technology, new product development, Green Solutions, and precision agriculture technologies.
Peer Outperformance in Fertilizers & Agricultural Chemicals
| Ticker | Name | Rev Growth 3Y Avg | P/E | 1Y | 3Y | 5Y | 5Y Gap |
|---|---|---|---|---|---|---|---|
| AVD | American Vanguard | -3.5% | -1.1x | -59.4% | -84.0% | -85.4% | — |
| CF | CF Industries | -1.0% | 9.2x | 48.2% | 74.8% | 207.6% | +293pp |
| NTR | Nutrien | -4.8% | 14.8x | 32.0% | 30.4% | 44.1% | +130pp |
| SMG | Scotts Miracle Gro | -1.6% | 47.6x | 3.2% | 21.2% | -53.1% | +32pp |
| Industry | Names | 1Y med | 3Y med | 5Y med | Top 3 by 5Y |
|---|---|---|---|---|---|
| Copper | 7 | 113.8% | 93.2% | 313.3% | COPR 1027% · TGB 416% · HBM 384% |
| Silver | 6 | 152.1% | 318.4% | 163.9% | AYA 254% · HL 238% · SVM 199% |
| Gold | 32 | 47.6% | 196.7% | 155.6% | IAG 765% · CNL 533% · KGC 466% |
| Steel | 13 | 26.1% | 47.1% | 129.5% | AMR 509% · HCC 429% · NWPX 332% |
| Diversified Metals & Mining | 24 | 4.6% | -7.8% | 50.3% | ATLX 224900% · USAR 60269% · SGML 913% |
| Aluminum | 3 | 105.5% | 129.3% | 48.5% | CENX 263% · KALU 48% · AA 19% |
| Construction Materials | 7 | -14.0% | 26.7% | 43.4% | USLM 318% · CRH 95% · VMC 54% |
| Metal, Glass & Plastic Containers | 11 | -3.1% | 4.3% | 5.4% | KRT 168% · MYE 68% · GEF 56% |
| Paper & Plastic Packaging Products & Materials | 7 | 9.7% | 12.8% | -7.2% | PKG 84% · CCK 14% · SON 5% |
| Precious Metals & Minerals | 9 | 45.0% | 152.4% | -7.9% | ASM 632% · PPTA 395% · ELE 108% |
| Specialty Chemicals | 40 | 10.5% | -2.9% | -12.4% | LWLG 758% · ODC 478% · NEU 190% |
| Commodity Chemicals | 13 | 25.6% | 13.7% | -16.9% | HWKN 233% · MEOH 71% · LXU 64% |
| Diversified Chemicals | 4 | 4.3% | -28.6% | -27.6% | CBT 74% · ASH -10% · CC -45% |
| Fertilizers & Agricultural Chemicals ← | 10 | -6.1% | -6.2% | -35.2% | CF 208% · CTVA 101% · NTR 44% |
| Paper Products | 3 | -12.3% | -51.5% | -95.6% | CLW -36% · ITP -96% · MERC -96% |
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| American Vanguard Earnings Notes | 12/16/2025 | |
| Would You Still Hold American Vanguard Stock If It Fell Another 30%? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 48.56 |
| Mkt Cap | 13.4 |
| Rev LTM | 9,993 |
| Op Inc LTM | 1,684 |
| FCF LTM | 357 |
| FCF 3Y Avg | 733 |
| CFO LTM | 828 |
| CFO 3Y Avg | 1,674 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 6.2% |
| Rev Chg 3Y Avg | -4.1% |
| Rev Chg Q | -3.6% |
| QoQ Delta Rev Chg LTM | -0.9% |
| Op Inc Chg LTM | 30.1% |
| Op Inc Chg 3Y Avg | -19.6% |
| Op Mgn LTM | 10.3% |
| Op Mgn 3Y Avg | 12.5% |
| QoQ Delta Op Mgn LTM | -0.4% |
| CFO/Rev LTM | 5.8% |
| CFO/Rev 3Y Avg | 11.3% |
| FCF/Rev LTM | 3.1% |
| FCF/Rev 3Y Avg | 5.9% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Developing, manufacturing and distributing chemical, biological and biorational products for | 515 | 547 | 579 | 610 | |
| Single Segment | 558 | ||||
| Total | 515 | 547 | 579 | 610 | 558 |
| $ Mil | 2025 | 2024 | 2023 |
|---|---|---|---|
| Developing, manufacturing and distributing chemical, biological and biorational products for | -28 | -102 | 23 |
| Total | -28 | -102 | 23 |
| $ Mil | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Developing, manufacturing and distributing chemical, biological and biorational products for | -50 | -126 | 8 | 27 |
| Total | -50 | -126 | 8 | 27 |
Price Behavior
| Market Price | $2.19 | |
| Market Cap ($ Bil) | 0.1 | |
| First Trading Date | 06/22/1988 | |
| Distance from 52W High | -62.3% | |
| 50 Days | 200 Days | |
| DMA Price | $2.55 | $3.43 |
| DMA Trend | down | down |
| Distance from DMA | -14.1% | -36.2% |
| 3M | 1YR | |
| Volatility | 67.9% | 66.5% |
| Downside Capture | 183.01 | 171.81 |
| Upside Capture | 91.33 | 29.99 |
| Correlation (SPY) | 10.9% | 17.9% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 2.24 | 0.41 | 0.81 | 1.06 | 0.90 | 0.85 |
| Up Beta | 0.49 | -1.77 | -0.58 | 0.12 | 0.75 | 0.98 |
| Down Beta | 4.67 | 0.51 | 0.50 | 2.17 | 1.28 | 0.88 |
| Up Capture | 88% | 87% | 79% | 18% | 43% | 7% |
| Bmk +ve Days | 11 | 22 | 35 | 67 | 138 | 427 |
| Stock +ve Days | 11 | 22 | 30 | 57 | 126 | 363 |
| Down Capture | 311% | 125% | 180% | 172% | 111% | 105% |
| Bmk -ve Days | 11 | 21 | 28 | 59 | 114 | 326 |
| Stock -ve Days | 11 | 19 | 30 | 62 | 113 | 355 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with AVD | |
|---|---|---|---|---|
| AVD | -59.6% | 66.2% | -1.10 | - |
| Sector ETF (XLB) | 17.2% | 17.8% | 0.74 | 34.4% |
| Equity (SPY) | 20.1% | 12.8% | 1.16 | 18.0% |
| Gold (GLD) | 30.9% | 29.0% | 0.92 | 14.7% |
| Commodities (DBC) | 39.9% | 20.3% | 1.54 | -8.8% |
| Real Estate (VNQ) | 9.9% | 13.7% | 0.44 | 30.8% |
| Bitcoin (BTCUSD) | -30.1% | 43.7% | -0.70 | 10.0% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with AVD | |
|---|---|---|---|---|
| AVD | -31.7% | 55.8% | -0.46 | - |
| Sector ETF (XLB) | 6.9% | 19.1% | 0.25 | 34.4% |
| Equity (SPY) | 13.1% | 17.2% | 0.59 | 24.3% |
| Gold (GLD) | 19.7% | 18.7% | 0.85 | 10.1% |
| Commodities (DBC) | 11.5% | 19.6% | 0.46 | 5.9% |
| Real Estate (VNQ) | 2.0% | 18.9% | 0.00 | 26.0% |
| Bitcoin (BTCUSD) | 9.6% | 52.7% | 0.37 | 11.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with AVD | |
|---|---|---|---|---|
| AVD | -18.2% | 48.9% | -0.22 | - |
| Sector ETF (XLB) | 10.2% | 20.7% | 0.44 | 45.2% |
| Equity (SPY) | 15.2% | 17.9% | 0.72 | 37.0% |
| Gold (GLD) | 12.2% | 16.3% | 0.61 | 7.7% |
| Commodities (DBC) | 7.3% | 18.0% | 0.33 | 12.6% |
| Real Estate (VNQ) | 5.0% | 20.7% | 0.20 | 34.1% |
| Bitcoin (BTCUSD) | 63.4% | 66.1% | 1.03 | 10.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Updated 6/8/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 3/18/2026 | -13.6% | -27.8% | -12.6% |
| 11/12/2025 | 3.3% | -2.9% | -11.3% |
| 8/1/2025 | 3.3% | 10.5% | 28.3% |
| 6/6/2025 | 1.6% | -7.0% | -13.8% |
| 3/14/2025 | -5.7% | 1.1% | -20.0% |
| 11/12/2024 | 9.2% | 7.8% | -10.5% |
| 8/9/2024 | 9.4% | 11.3% | 18.2% |
| 5/10/2024 | 1.4% | -0.4% | -3.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 13 | 11 | 9 |
| # Negative | 10 | 12 | 14 |
| Median Positive | 1.9% | 5.6% | 14.4% |
| Median Negative | -2.9% | -5.1% | -9.4% |
| Max Positive | 9.4% | 11.3% | 28.3% |
| Max Negative | -13.6% | -27.8% | -20.0% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 3/18/2026 | -13.6% | -27.8% | -12.6% |
| 11/12/2025 | 3.3% | -2.9% | -11.3% |
| 8/1/2025 | 3.3% | 10.5% | 28.3% |
| 6/6/2025 | 1.6% | -7.0% | -13.8% |
| 3/14/2025 | -5.7% | 1.1% | -20.0% |
| 11/12/2024 | 9.2% | 7.8% | -10.5% |
| 8/9/2024 | 9.4% | 11.3% | 18.2% |
| 5/10/2024 | 1.4% | -0.4% | -3.5% |
| 3/18/2024 | 4.7% | 8.0% | -3.4% |
| 11/9/2023 | -7.5% | -5.1% | 3.5% |
| 8/9/2023 | 1.9% | 5.6% | -8.3% |
| 5/10/2023 | -1.7% | 5.5% | 9.6% |
| 3/14/2023 | -3.2% | 3.0% | 3.2% |
| 11/10/2022 | -2.0% | -0.4% | -1.4% |
| 8/11/2022 | 1.6% | 1.2% | 2.6% |
| 5/4/2022 | 2.5% | -5.0% | 14.4% |
| 3/11/2022 | 1.4% | 9.5% | 24.7% |
| 11/10/2021 | 0.3% | -7.3% | -15.0% |
| 8/10/2021 | -4.0% | -7.3% | -4.7% |
| 5/7/2021 | -2.6% | -4.5% | -10.5% |
| 3/16/2021 | 0.1% | -7.2% | -5.6% |
| 11/12/2020 | -2.1% | 2.8% | 14.6% |
| 8/10/2020 | -0.8% | -3.0% | -5.4% |
| SUMMARY STATS | |||
| # Positive | 13 | 11 | 9 |
| # Negative | 10 | 12 | 14 |
| Median Positive | 1.9% | 5.6% | 14.4% |
| Median Negative | -2.9% | -5.1% | -9.4% |
| Max Positive | 9.4% | 11.3% | 28.3% |
| Max Negative | -13.6% | -27.8% | -20.0% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/10/2026 | 10-Q |
| 03/31/2026 | 05/06/2026 | 10-Q |
| 12/31/2025 | 03/16/2026 | 10-K |
| 09/30/2025 | 11/10/2025 | 10-Q |
| 06/30/2025 | 07/31/2025 | 10-Q |
| 03/31/2025 | 06/06/2025 | 10-Q |
| 12/31/2024 | 05/29/2025 | 10-K |
| 09/30/2024 | 11/12/2024 | 10-Q |
| 06/30/2024 | 08/09/2024 | 10-Q |
| 03/31/2024 | 05/09/2024 | 10-Q |
| 12/31/2023 | 03/28/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/09/2023 | 10-Q |
| 03/31/2023 | 05/10/2023 | 10-Q |
| 12/31/2022 | 03/16/2023 | 10-K |
| 09/30/2022 | 11/08/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/10/2026 | 10-Q |
| 03/31/2026 | 05/06/2026 | 10-Q |
| 12/31/2025 | 03/16/2026 | 10-K |
| 09/30/2025 | 11/10/2025 | 10-Q |
| 06/30/2025 | 07/31/2025 | 10-Q |
| 03/31/2025 | 06/06/2025 | 10-Q |
| 12/31/2024 | 05/29/2025 | 10-K |
| 09/30/2024 | 11/12/2024 | 10-Q |
| 06/30/2024 | 08/09/2024 | 10-Q |
| 03/31/2024 | 05/09/2024 | 10-Q |
| 12/31/2023 | 03/28/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/09/2023 | 10-Q |
| 03/31/2023 | 05/10/2023 | 10-Q |
| 12/31/2022 | 03/16/2023 | 10-K |
| 09/30/2022 | 11/08/2022 | 10-Q |
| 06/30/2022 | 08/08/2022 | 10-Q |
| 03/31/2022 | 05/04/2022 | 10-Q |
| 12/31/2021 | 03/14/2022 | 10-K |
| 09/30/2021 | 11/08/2021 | 10-Q |
| 06/30/2021 | 08/10/2021 | 10-Q |
| 03/31/2021 | 05/07/2021 | 10-Q |
| 12/31/2020 | 03/31/2021 | 10-K |
| 09/30/2020 | 11/09/2020 | 10-Q |
| 06/30/2020 | 08/07/2020 | 10-Q |
| 03/31/2020 | 05/11/2020 | 10-Q |
| 12/31/2019 | 03/10/2020 | 10-K |
| 09/30/2019 | 11/06/2019 | 10-Q |
Recent Forward Guidance
Updated 8/18/2026Latest: Q2 2026 Earnings Reported 8/11/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Adjusted EBITDA | 44.00 Mil | 46.00 Mil | 48.00 Mil | 0 | Affirmed | Guidance: 46.00 Mil for 2026 | |
| 2026 Revenue | 530.00 Mil | 540.00 Mil | 550.00 Mil | ||||
| 2026 Cost Savings | 4.00 Mil | ||||||
Prior: Q4 2025 Earnings Reported 3/18/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Adjusted EBITDA | 44.00 Mil | 46.00 Mil | 48.00 Mil | 9.5% | Higher New | Guidance: 42.00 Mil for 2025 | |
Q3 2025 Earnings Reported 11/12/2025
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2025 Adjusted EBITDA | 40.00 Mil | 42.00 Mil | 44.00 Mil | 0 | Affirmed | Guidance: 42.00 Mil for 2025 | |
Insider Activity
Updated 8/20/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Rosenbloom, Keith M | See Footnote | Sell | 8202026 | 2.20 | 556,580 | 1,224,476 | 33,442 | Form | |
| 2 | MacIcek, Steven D | Direct | Buy | 8182026 | 2.09 | 19,000 | 39,710 | 208,396 | Form | |
| 3 | Kaye, Douglas | CHIEF EXECUTIVE OFFICER | Direct | Buy | 6052026 | 2.50 | 5,000 | 12,500 | 750,628 | Form |
| 4 | Gottschalk, Patrick E | Direct | Buy | 5192026 | 2.70 | 25,000 | 67,500 | 517,604 | Form | |
| 5 | Gottschalk, Patrick E | Direct | Buy | 5142026 | 2.95 | 20,000 | 59,000 | 491,780 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Rosenbloom, Keith M | See Footnote | Sell | 8202026 | 2.20 | 556,580 | 1,224,476 | 33,442 | Form | |
| 2 | MacIcek, Steven D | Direct | Buy | 8182026 | 2.09 | 19,000 | 39,710 | 208,396 | Form | |
| 3 | Kaye, Douglas | CHIEF EXECUTIVE OFFICER | Direct | Buy | 6052026 | 2.50 | 5,000 | 12,500 | 750,628 | Form |
| 4 | Gottschalk, Patrick E | Direct | Buy | 5192026 | 2.70 | 25,000 | 67,500 | 517,604 | Form | |
| 5 | Gottschalk, Patrick E | Direct | Buy | 5142026 | 2.95 | 20,000 | 59,000 | 491,780 | Form | |
| 6 | Gottschalk, Patrick E | Direct | Buy | 5142026 | 2.92 | 20,000 | 58,400 | 428,379 | Form | |
| 7 | Eilers, Peter | See Remarks | Direct | Sell | 9052025 | 5.35 | 6,000 | 32,100 | 172,147 | Form |
Industry Resources
| Materials Resources |
| Chemical & Engineering News (C&EN) |
| Mining.com |
| Plastics News |
| Fertilizers & Agricultural Chemicals Resources |
| World Fertilizer |
| Fertilizer Daily |
| Argus Media - Fertilizer |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.